A fund developed by Saskatchewan pharmacists to develop and support alternative reimbursement programs is being tapped this year to support the minor ailment assessment program.
OTTAWA | The manufacturer of a drug used to treat multiple sclerosis is issuing new safety recommendations aimed at reducing the risk of serious heart-related side-effects when patients first start taking the medication.